Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MET
MET logo

MET Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy MetLife Inc (MET) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
77.700
1 Day change
-0.49%
52 Week Range
83.850
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

MetLife Inc (MET) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently trading in pre-market with a slight positive movement, but the financial performance shows declining net income and EPS, which raises concerns. Additionally, hedge funds are aggressively selling, and there are no recent positive news catalysts or significant insider activity to support a bullish case. While options data shows a slightly bullish sentiment in volume, the high Open Interest Put-Call Ratio indicates caution. Analyst ratings are mixed with lowered price targets, reflecting challenges in the life insurance sector. Given the user's impatience and unwillingness to wait for optimal entry points, it is better to hold off on investing in MET at this time.

Technical Analysis

The MACD is positive at 0.937, showing bullish momentum, but it is contracting. RSI is at 78.514, indicating a neutral zone. Moving averages are converging, suggesting indecision in the market. Key resistance levels are at 77.235 and 79.271, while support levels are at 73.938 and 70.641. The stock is trading near its resistance levels, which may limit further upside in the short term.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The Open Interest Put-Call Ratio of 1.6 indicates a bearish sentiment, while the Option Volume Put-Call Ratio of 0.88 suggests slightly bullish trading sentiment. Implied volatility is high at 31.43%, with an 82.4% IV percentile, indicating elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
11

Positive Catalysts

  • No significant positive catalysts. The stock shows a 60% chance of gaining 4.15% in the next week based on historical patterns.

Neutral/Negative Catalysts

  • Hedge funds are aggressively selling, with a 119940.49% increase in selling activity over the last quarter. Declining net income and EPS in the latest quarter. Analysts have lowered price targets, reflecting challenges in the life insurance sector.

Financial Performance

In Q4 2025, revenue increased by 26.69% YoY to $23.67 billion. However, net income dropped by 37.21% YoY to $778 million, and EPS fell by 34.27% YoY to 1.17. Gross margin remained unchanged.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Several firms have lowered price targets, citing challenges in the life insurance sector, including premium growth concerns and economic uncertainty. The average price target is around $93, which suggests potential upside, but the sentiment is cautious overall.

Wall Street analysts forecast MET stock price to rise
12 Analyst Rating
Wall Street analysts forecast MET stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 77.700
sliders
Low
84
Averages
95.25
High
108
Current: 77.700
sliders
Low
84
Averages
95.25
High
108
BofA
Buy
maintain
$103 -> $99
AI Analysis
2026-04-14
Reason
BofA
Price Target
$103 -> $99
AI Analysis
2026-04-14
maintain
Buy
Reason
BofA lowered the firm's price target on MetLife to $99 from $103 and keeps a Buy rating on the shares. The firm adjusted price target among its U.S. insurance coverage to reflect Q4 events and changes to peer multiples.
Mizuho
Yaron Kinar
Outperform
to
Outperform
downgrade
$100 -> $93
2026-04-13
Reason
Mizuho
Yaron Kinar
Price Target
$100 -> $93
2026-04-13
downgrade
Outperform
to
Outperform
Reason
Mizuho analyst Yaron Kinar lowered the firm's price target on MetLife to $93 from $100 and keeps an Outperform rating on the shares. The firm adjusted estimates and targets among its North America insurance coverage, stating that it is most constructive on brokers, expects commercial pricing pressure moderation among property and casualty insurers and believes the setup for life insurers is "the most challenging."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MET
Unlock Now

People Also Watch